Elena joined GammaDelta Therapeutics in April 2021 and brings over 15 years’ experience in business development in both pharma and biotech. She joined GammaDelta from Ipsen Pharma where she held roles of increasing responsibility in Business development most recently as VP Global Head Oncology Business Development. Prior to Ipsen Elena held Business Development roles at Sanofi Genzyme, Genzyme and start up biotech. Elena has broad experience across different types of deals and therapeutic areas as well as corporate strategy and integration. She has led a wide range of transactions spanning through discovery stage to marketed assets licensing and acquisitions.

Elena holds a BSc (Hons) in Immunology from the University of Edinburgh, a PhD from the German Cancer Research Centre (DKFZ), and an MBA from HEC Business School.